Form 4 for NEO NEOGENOMICS INC
Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-21 · accession 0001628280-26-011102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-24 | 2026-02-21+ | NEO | Stone Warren | Pres, COO | F - Tax | $0.00 | -10.5K | 142.6K | -7% | $0 |
| DM | 2026-02-24 | 2026-02-21+ | NEO | Stone Warren | Pres, COO | M - OptEx | $0.00 | +36.5K | 149.7K | +32% | $0 |
| DM | 2026-02-24 | 2026-02-21+ | NEO | Stone Warren | Pres, COO | M - OptEx | $0.00 | -36.5K | 8,443 | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | F | D | 3,323 | $0.00 | 147,714 | D | — | — | (F2) Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. |
| 2 | Common | Common Stock | 2026-02-23 | M | A | 8,443 | $0.00 | 151,037 | D | — | — | (F1) Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. |
| 3 | Common | Common Stock | 2026-02-21 | F | D | 7,142 | $0.00 | 142,594 | D | — | — | (F2) Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. |
| 4 | Common | Common Stock | 2026-02-21 | M | A | 28,105 | $0.00 | 149,736 | D | — | — | (F1) Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. |
| 5 | Derivative | Restricted Stock Unit | 2026-02-21 | M | D | 28,105 | $0.00 | 56,212 | D | $0.00 · — to — | 28,105 Common Stock | (F3) On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone'spromotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grantdate. (F4) Once vested, the shares of common stock are not subject to expiration. |
| 6 | Derivative | Restricted Stock Unit | 2026-02-23 | M | D | 8,443 | $0.00 | 8,443 | D | $0.00 · — to — | 8,443 Common Stock | (F5) On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. (F4) Once vested, the shares of common stock are not subject to expiration. |